Jimini Health – a digital health company setting a new standard in mental healthcare with its clinician-led therapy model augmented by responsible AI – announced its launch with $8 million in pre-seed funding, including from Zetta Venture Partners, LionBird, PsyMed, BoxGroup, Arkitekt Ventures, SCB, and others.
Jimini Health is creating a better mental health experience for patients with various mental health conditions and improving outcomes through an innovative blend of expert human therapists and safe, clinically-integrated AI. And the company has combined evidence-based therapy and continuous support in between sessions with its clinically supervised AI therapist assistant Sage to provide patients with a safe, immersive experience that is impossible with traditional therapy. Therapy is also far more effective when practiced outside of sessions, but until now, these approaches have not been scalable.
Jimini Health will utilize its funding to develop its AI, data, safety operations, and products to serve its initial clients. Headed by a human therapist, Jimini’s AI-supported approach combines traditional evidence-based therapy modalities, such as cognitive behavior therapy, with an AI therapist assistant, Sage, to provide users with tailored prompts and exercises aligned with their therapeutic goals. This model keeps patients involved daily in clinically helpful activities, reinforcing their progress.
Founded by industry leaders Luis Voloch, Mark Jacobstein, and Sahil Sud—each with a background in AI, healthcare, and biotechnology—Jimini Health brings together expertise from healthcare and technology to create an evidence-backed, clinician-led mental health model. Luis Voloch (Jimini Health CEO and co-founder), formerly co-founder at Immunai, an AI-driven cancer immunotherapy company valued at over $1 billion, brings deep AI and biotech experience alongside Jacobstein (ex-Guardant Health, Immunai) and Sud (ex-Ribbon Health, Palantir Technologies). The founding team aims to redefine therapy through a modern, science-based approach.
Jimini Health’s AI is integrated directly into a patient’s care plan and overseen by a licensed therapist. And this structure ensures that Sage reinforces therapeutic objectives safely, adapting to each patient’s unique needs without jeopardizing clinical rigor or patient privacy. With this model, Jimini Health mitigates the risks of unsupervised AI tools that may offer generic advice or, worse, unsafe responses during times of patient distress.
Jimini Health is working with renowned psychology experts from leading research institutions like Harvard, Yale, and Stanford, ensuring that the latest clinical research backs its therapeutic practices. And Sage as a supporting element to keep patients engaged and reinforce therapeutic skills between sessions.
Jimini’s AI Sage was developed to offer real-time, evidence-based support, with supervision and safety as core principles. And it provides tools for managing immediate concerns and reinforcing therapeutic techniques, supporting a continuous care model that is both effective and patient-centric. The AI assistant’s actions are shaped by each patient’s unique treatment plan, which the therapist develops.
KEY QUOTES:
“Therapy has been constrained by a traditional once-a-week model that leaves patients unsupported between sessions— a shortcoming that can be overcome with LLMs. We’re thrilled to attract a top-tier syndicate of AI and healthcare investors who support our approach. Our mission is to integrate responsible AI to superpower our clinicians, rather than replace them, to offer a new standard of continuous, higher quality care.”
– Luis Voloch, CEO and co-founder of Jimini Health
“Mental illness is a global health emergency, but is too often treated by startups as a consumer marketing problem. Coming from a unique AI and biotech background, the founders of Jimini understand the challenges of managing complex diseases and are bringing the same level of scientific rigor, technological sophistication, and clinical excellence to Jimini. The promise and perils of AI for treating mental health conditions have become painfully clear recently, and the stakes could not be higher for doing it safely.”
– Dylan Reid, Partner, Zetta Venture Partners
“This approach is a significant step forward in mental health care, combining the advantages of technology with evidence-based psychology.”
– Johannes Eichstaedt, Ph.D., Professor of Psychology at Stanford University
“For over 10 years, we have seen the same kind of mental health delivered online over and over again. Jimini is the first to harness AI to provide the best foundations for new forms of therapy in the 21st century, anytime, anywhere.”
– Dr. Gal Noyman Veksler, Partner at LionBird and a trained Psychologist
“LLMs coupled with clinicians have the potential to radically improve outcomes in therapy for the first time in decades. The Jimini team is doing just that.”
– Adviser David Feinberg, previous CEO at Geisinger and now Chairman at Oracle Health
